-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Re-Anticoagulation After Bleeding

Program: Spotlight Sessions
Session: Challenging Anticoagulation Scenarios
Monday, December 7, 2015, 2:45 PM-4:15 PM
W315, Level 3 (Orange County Convention Center)

Scott Kaatz, DO, MSc

Hurley Medical Center, Flint, MI

Disclosures: Kaatz: Janssen: Honoraria , Speakers Bureau ; Boehringer-Ingelheim: Honoraria , Speakers Bureau ; Bristol Myer Squibb/Pfizer: Honoraria , Speakers Bureau ; CSL Behring: Speakers Bureau ; Daiichi Sankyo: Honoraria , Speakers Bureau .

See more of: Challenging Anticoagulation Scenarios
See more of: Spotlight Sessions
<< Previous Presentation | Next Presentation